English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech Healthcare & Pharm
애질렉스 바이오랩스의 고객사 샤스키, 임상 프로그램 착수하며 사상 최초 인체 적용 클릭 화학 기술 발표
Oct 30, 2020 11:00 HKT
아방스 클리니컬, 마스터 컨트롤 2020 혁신 우수상 수상
Oct 30, 2020 11:00 HKT
Avance Clinical Wins MasterControl 2020 Innovation Excellence Award
Oct 30, 2020 05:00 HKT
Agilex Biolabs客户Shasqi宣布点击化学启动临床程序首次实现人类应用的突破
Oct 30, 2020 05:00 HKT
Agilex Biolabs客戶Shasqi宣佈點擊化學啟動臨床程序首次實現人類應用的突破
Oct 30, 2020 05:00 HKT
Avance Clinical榮獲MasterControl 2020創新卓越獎
Oct 30, 2020 05:00 HKT
Avance Clinical荣获MasterControl 2020创新卓越奖
Oct 30, 2020 05:00 HKT
Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Program
Oct 30, 2020 01:00 HKT
荣昌生物昨日招股 基石投资总计2.275亿美元
Oct 29, 2020 11:52 HKT
榮昌生物昨日招股 基石投資總計2.275億美元
Oct 29, 2020 11:51 HKT
荣昌生物启动招股 研发药物属同类首创
Oct 28, 2020 11:22 HKT
榮昌生物啟動招股 研發藥物屬同類首創
Oct 28, 2020 11:21 HKT
엔드포인트 뉴스, 바이오 유럽 2020에서 ‘차세대 임상시험, 왜 호주와 애질렉스 바이오랩스인가’ 선보여
Oct 28, 2020 08:00 HKT
Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma - announced at Bio-Europe 2020
Oct 28, 2020 00:03 HKT
端点新闻为Bio Europe提出“为什么要在澳大利亚和Agilex Biolabs进行下一次临床试验”2020
Oct 27, 2020 13:00 HKT
端點新聞為Bio Europe提出“為什麼要在澳大利亞和Agilex Biolabs進行下一次臨床試驗”2020
Oct 27, 2020 13:00 HKT
Endpoints News Presents "Why Australia and Agilex Biolabs for your Next Clinical Trial" for Bio Europe 2020
Oct 27, 2020 12:00 HKT
Epazz DeskFlex Room Booking System Sees Demand Coming From Asia Pacific Region; Advances COVID-Compliant Software Suite For Specific Functionality
Oct 22, 2020 01:00 HKT
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
Oct 21, 2020 21:00 HKT
Olympus to Support Endoscopic AI Diagnosis Education for Doctors in India and to Launch AI Diagnostic Support Application
Oct 20, 2020 10:00 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: